Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 10—October 2016

Chikungunya Virus in Febrile Humans and Aedes aegypti Mosquitoes, Yucatan, Mexico

Article Metrics
citations of this article
EID Journal Metrics on Scopus
Nohemi Cigarroa-Toledo, Bradley J. Blitvich, Rosa C. Cetina-Trejo, Lourdes G. Talavera-Aguilar, Carlos M. Baak-Baak, Oswaldo M. Torres-Chablé, Md-Nafiz Hamid, Iddo Friedberg, Pedro González-Martinez, Gabriela Alonzo-Salomon, Elsy P. Rosado-Paredes, Nubia Rivero-Cárdenas, Guadalupe C. Reyes-Solis, Jose A. Farfan-Ale, Julian E. Garcia-Rejon, and Carlos Machain-WilliamsComments to Author 
Author affiliations: Universidad Autonoma de Yucatan, Merida, Mexico (N. Cigarroa-Toledo, R.C. Cetina-Trejo, L.G. Talavera-Aguilar, C.M. Baak-Baak, O.M. Torres-Chablé, P. González-Martinez, G. Alonzo-Salomon, E.P. Rosado-Paredes, N. Rivero-Cárdenas, G.C. Reyes-Solis, J.A. Farfan-Ale, J.E. Garcia-Rejon, C. Machain-Williams); Iowa State University, Ames, Iowa, USA (B.J. Blitvich, M. Hamid, I. Friedberg)

Cite This Article


Chikungunya virus (CHIKV) was isolated from 12 febrile humans in Yucatan, Mexico, in 2015. One patient was co-infected with dengue virus type 1. Two additional CHIKV isolates were obtained from Aedes aegypti mosquitoes collected in the homes of patients. Phylogenetic analysis showed that the CHIKV isolates belong to the Asian lineage.

Chikungunya virus (CHIKV; family Togaviridae, genus Alphavirus) is transmitted to humans by Aedes spp. mosquitoes (1,2). The virus is the etiologic agent of chikungunya, an acute febrile illness that is often accompanied by debilitating arthralgia. Historically, CHIKV has been restricted to the Eastern Hemisphere, but in 2013, the virus was reported in the Western Hemisphere during a large outbreak in the Caribbean region. CHIKV spread rapidly to South America, Central America, Mexico, and the United States. The Pan American Health Organization estimated that >1.7 million suspected and laboratory-confirmed cases of chikungunya have occurred in the Western Hemisphere (http://www.paho. org/hq/index.php?option=com_topics&view=readall&cid=5927&Itemid=40931&lang=en).

CHIKV was isolated in Mexico from a patient from Jalisco in whom symptoms developed in May 2014 shortly after the patient returned from the Caribbean region (3). The first autochthonous case was reported in October 2014 after CHIKV was isolated from a patient in southeastern state of Chiapas (4). CHIKV-infected Aedes aegypti mosquitoes and additional chikungunya cases were identified in Chiapas later in 2014 (5,6). To our knowledge, no reports of CHIKV in any other states in Mexico have been published. In this study, we tested febrile patients in the state of Yucatan and mosquitoes temporally and spatially associated with these patients for CHIKV infection.

The Study

We obtained written informed consent from all patients who participated in the study or their legal guardians. The study population was composed of patients who came to hospitals or clinics in Yucatan during August–October 2015 with chikungunya-like illness. These patients were referred to the hematology laboratory at the Hideyo Noguchi Research Center (Merida, Yucatan, Mexico). A patient was considered to have chikungunya-like illness if he or she had fever and arthralgia. Travel history of each study participant was recorded, and any patient who had traveled outside Yucatan in the past 30 days before disease onset was excluded from the study.

Blood was collected from the cephalic vein of each patient, dispensed into a vacutainer tube (BD Diagnostics, Franklin Lakes, NJ, USA), and centrifuged. Serum was collected and stored at −80°C. Resting mosquitoes were collected from the homes of each study participant by using Centers for Disease Control and Prevention (Atlanta, GA, USA) backpack-mounted aspirators. Each house was examined once, and collections were made between 9:00 am and noon. All rooms were inspected, particularly dark areas (i.e., underneath furniture, in closets, and in curtains). Backyards were also searched, particularly shaded areas (i.e., pet homes, tool sheds, and underneath vegetation).

Mosquitoes were transported alive to the laboratory and identified on chill tables by using morphologic characteristics (7). Female mosquitoes were sorted into pools of <10 and homogenized in phosphate-buffered saline (pH 7.2) by using a mortar and pestle. Male mosquitoes were discarded.

An aliquot of each serum sample and mosquito homogenate was filtered and inoculated onto subconfluent monolayers of Ae. albopictus (C6/36) cells in 25-cm2 flasks. Cells were incubated for 7 days at 28°C. Second and third blind passages were performed in C6/36 and African green monkey kidney (Vero) cells, respectively. Vero cells were incubated for 3–7 days at 37°C in an atmosphere of 5% CO2. Cells were scraped from flasks after each passage and centrifuged at 10,000 × g for 10 min at 4°C. Supernatants were collected and stored at −80°C. Cell pellets were resuspended in Trizol (Invitrogen, Carlsbad, CA, USA), and total RNA was extracted following the manufacturer’s instructions.

We analyzed total RNA by using reverse transcription PCR (RT-PCR) and CHIKV-specific primers for a 107-nt region of the nonstructural protein 1 gene (primer sequences available upon request from the authors) and dengue virus (DENV)–specific primers for a 511-nt region of the capsid–membrane genes of all 4 serotypes (8). If DENV RNA was detected, we performed a semi-nested RT-PCR with serotype-specific primers. If CHIKV RNA was detected, we amplified a 3,744-nt region that spans the structural protein genes (capsid-E3-E2-6K-E1) (E, envelope; 6K, membrane-associated peptide) as 2 overlapping fragments (primer sequences available upon request from the authors).

Complementary DNAs were generated by using Superscript III reverse transcriptase (Invitrogen), and PCRs were performed by using Taq polymerase (Invitrogen). RT-PCR products were purified by using the Purelink Gel Extraction Kit (Invitrogen) and sequenced by using a 3730x1 DNA sequencer (Applied Biosystems, Foster City, CA, USA).

We isolated CHIKV from 12 (23.5%) of 51 study participants. DENV type 1 was also isolated from 1 CHIKV-positive patient. DENV was readily detected in cultured cells after the first blind passage, but its ability to replicate decreased after subsequent passages, presumably because CHIKV outcompeted this slower-replicating flavivirus.

The most common symptoms in patients infected with only CHIKV, in addition to fever, during the first 3 days of disease onset were arthralgia (100%), myalgia (100%), asthenia (90.9%), and rash (45.5%) (Table). Symptoms of the co-infected patient (a 31-year-old woman) included headache, myalgia, and rash. Age range of patients infected with only CHIKV was 9–59 years (mean age 31 years).

We collected a total of 237 female mosquitoes, and all were identified as Ae. aegypti mosquitoes. CHIKV was isolated from 2 pools. One pool contained mosquitoes collected in the living room of a 53-year-old patient who had a confirmed CHIKV infection. The other pool contained mosquitoes collected in bedroom of the co-infected patient. DENV was not isolated from any mosquitoes.

The capsid-E3-E2-6K-E1 region of each CHIKV isolate was sequenced and submitted to GenBank under accession nos. KU295117–KU295130. Pairwise alignments of the nucleotide and deduced amino acid sequences were performed by using Clustal Omega ( msa/clustalo/). Analysis showed that nucleotide sequences had 99.41%–99.97% identity and amino acid sequences 99.44%–100% identity with each other. The nucleotide sequence of 1 isolate (GenBank accession no. KU295121) was aligned with all other CHIKV sequences in GenBank and shown to have highest identity (99.52%) with the corresponding gene region of CHIKV isolates from Panama and El Salvador, followed by an identity of 99.49% with isolates from Chiapas, Mexico; Guatemala; Puerto Rico; Guyana; and elsewhere in the Western Hemisphere. Analysis of deduced amino acid sequences showed that mutations associated with increased infectivity of Ae. albopictus mosquitoes (E1-A226V and E2-L210Q) (9,10) were not present in genomes of any isolates.


Thumbnail of Phylogenetic analysis of chikungunya virus (CHIKV) isolates from Yucatan, Mexico. Analysis was based on a 3,744-nt structural gene region (capsid-E3-E2-6K-E1) of 63 CHIKV isolates, including the 14 isolates from Yucatan. Sequences were aligned by using MUSCLE (11), and the tree was constructed by using the neighbor-joining algorithm as implemented in PHYLIP (12) and using ETE3 (Environment for Tree Exploration 3) (13). Isolates are identified by GenBank accession number, country, an

Figure. Phylogenetic analysis of chikungunya virus (CHIKV) isolates from Yucatan, Mexico. Analysis was based on a 3,744-nt structural gene region (capsid-E3-E2-6K-E1) of 63 CHIKV isolates, including the 14 isolates from Yucatan. Sequences...

Complete structural gene sequences of 60 CHIKV isolates, including the 14 isolates from Yucatan, were aligned by using MUSCLE (11), and phylogenetic trees were constructed by using the neighbor-joining algorithm as implemented in PHYLIP (12) (Figure). We observed 4 lineages, Asian, East/Central/South African, Indian Ocean, and West African lineages, which was consistent with results of previous studies (1,5). CHIKV isolates from Yucatan belonged to the Asian lineage and shared a close phylogenetic relationship with other isolates from the Western Hemisphere (Figure). Our isolates formed a nested clade within the Asian lineage. However, bootstrap support (0.61) for this topologic arrangement was not strong.


We isolated CHIKV from febrile patients and Ae. aegypti mosquitoes in Yucatan, Mexico, which provided additional evidence that this virus is spreading throughout the Americas at an alarming rate. Concurrent isolation of CHIKV and DENV from a patient in this study and patients in previous studies (14,15) underscores the need for differential diagnosis in areas where these viruses co-circulate.

Ms. Cigarroa-Toledo is a graduate student in the Arbovirus Laboratory at the Universidad Autonoma de Yucatan, Merida, Mexico. Her research interests include arbovirus epidemiology, evolution, and surveillance.



We thank Irma Correa May for providing assistance during serum collection.

This study was supported by a grant (2014-247005) from Consejo Nacional de Ciencia y Tecnología de Mexico.



  1. Weaver  SC, Forrester  NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res. 2015;120:329. DOIPubMedGoogle Scholar
  2. Powers  AM. Risks to the Americas associated with the continued expansion of chikungunya virus. J Gen Virol. 2015;96:15. DOIPubMedGoogle Scholar
  3. Rivera-Ávila  RC. Chikungunya fever in Mexico: confirmed case and notes on the epidemiologic response [in Spanish]. Salud Publica Mex. 2014;56:4024.PubMedGoogle Scholar
  4. Díaz-Quinonez  JA, Ortiz-Alcantara  J, Fragoso-Fonseca  DE, Garces-Ayala  F, Escobar-Escamilla  N, Vazquez-Pichardo  M, Complete genome sequences of chikungunya virus strains isolated in Mexico: first detection of imported and autochthonous cases. Genome Announc. 2015;3:e0030015. DOIPubMedGoogle Scholar
  5. Kautz  TF, Diaz-Gonzalez  EE, Erasmus  JH, Malo-Garcia  IR, Langsjoen  RM, Patterson  EI, Chikungunya virus as cause of febrile illness outbreak, Chiapas, Mexico, 2014. Emerg Infect Dis. 2015;21:20703. DOIPubMedGoogle Scholar
  6. Díaz-González  EE, Kautz  TF, Dorantes-Delgado  A, Malo-Garcia  IR, Laguna-Aguilar  M, Langsjoen  RM, First report of Aedes aegypti transmission of chikungunya virus in the Americas. Am J Trop Med Hyg. 2015;93:13259. DOIPubMedGoogle Scholar
  7. Darsie  RF Jr. A survey and bibliography of the mosquito fauna of Mexico (Diptera: Culicidae). J Am Mosq Control Assoc. 1996;12:298306.PubMedGoogle Scholar
  8. Lanciotti  RS, Calisher  CH, Gubler  DJ, Chang  GJ, Vorndam  AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol. 1992;30:54551.PubMedGoogle Scholar
  9. Tsetsarkin  KA, Weaver  SC. Sequential adaptive mutations enhance efficient vector switching by chikungunya virus and its epidemic emergence. PLoS Pathog. 2011;7:e1002412. DOIPubMedGoogle Scholar
  10. Tsetsarkin  KA, Vanlandingham  DL, McGee  CE, Higgs  S. A single mutation in chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog. 2007;3:e201. DOIPubMedGoogle Scholar
  11. Edgar  RC. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004;32:17927. DOIPubMedGoogle Scholar
  12. Felsenstein  J. PHYLIP: Phylogeny Inference Package (version 3.2). Cladistics. 1989;5:1646.
  13. Huerta-Cepas  J, Dopazo  J, Gabaldon  T. ETE: a python environment for tree exploration. BMC Bioinformatics. 2010;11:24. DOIPubMedGoogle Scholar
  14. Chang  S-F, Su  C-L, Shu  P-Y, Yang  C-F, Liao  T-L, Cheng  C-H, Concurrent isolation of chikungunya virus and dengue virus from a patient with coinfection resulting from a trip to Singapore. J Clin Microbiol. 2010;48:45869. DOIPubMedGoogle Scholar
  15. Parreira  R, Centeno-Lima  S, Lopes  A, Portugal-Calisto  D, Constantino  A, Nina  J. Dengue virus serotype 4 and chikungunya virus coinfection in a traveller returning from Luanda, Angola, January 2014. Euro Surveill. 2014;19:20730. DOIPubMedGoogle Scholar




Cite This Article

DOI: 10.3201/eid2210.152087

Table of Contents – Volume 22, Number 10—October 2016

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.



Please use the form below to submit correspondence to the authors or contact them at the following address:

Carlos Machain-Williams, Laboratorio de Arbovirologia, Centro de Investigaciones Regionales Dr. Hideyo Noguchi, Universidad Autonoma de Yucatan, Merida, Yucatan, Mexico

Send To

10000 character(s) remaining.


Page created: September 19, 2016
Page updated: September 19, 2016
Page reviewed: September 19, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.